DCF — GARDEN CITY HOSPITAL OSTEOPATHIC
Enterprise Value: $148.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$148.1M
Enterprise Value
$39.9M
PV of Cash Flows
$108.2M
PV of Terminal Value
$174.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $152.1M | $18.2M | 12.0% | $8.2M | $7.4M |
| Year 2 | $156.7M | $20.4M | 13.0% | $9.6M | $7.9M |
| Year 3 | $161.4M | $22.6M | 14.0% | $11.1M | $8.3M |
| Year 4 | $166.2M | $24.1M | 14.0% | $12.1M | $8.2M |
| Year 5 | $171.2M | $25.2M | 15.0% | $12.8M | $7.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $148.1M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$147.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.11491400662297548
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5